Looks like another drug for Covid from a smaller company paired with one from Gilead just failed to meet expectations, so they're down 80% today. Would be nice to see leronlimab step in and crush it!

https://finance.yahoo.com/m/a1a382d1-d1af-3ac...s-67-.html